TheProfitWatch

MIST - Milestone Pharmaceuticals Inc. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.33 0.05 (2.36%) 0.0 (0.0%) 0.0 (0.0%) -0.01 (-0.42%) 0.04 (1.72%) 0.03 (1.49%) -0.07 (-2.9%) -0.04 (-1.66%)

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.2
Diluted EPS:
-0.2
Basic P/E:
-11.925
Diluted P/E:
-11.925
RSI(14) 1m:
46.14
VWAP:
2.39
RVol:

Events

Period Kind Movement Occurred At

Related News